Sammartano, V., Ciofini, S., Vangone, B.E., Carrara, C., Bocchia, M., Gozzetti, A. (2025). Efficacy and Safety of Teclistamab Followed by Autologous Stem Cell Transplant in Functional High-risk and Triple-class Refractory Multiple Myeloma. MEDITERRANEAN JOURNAL OF HEMATOLOGY AND INFECTIOUS DISEASES, 17(1) [10.4084/MJHID.2025.051].

Efficacy and Safety of Teclistamab Followed by Autologous Stem Cell Transplant in Functional High-risk and Triple-class Refractory Multiple Myeloma

Ciofini S.;Bocchia M.;Gozzetti A.
2025-01-01

2025
Sammartano, V., Ciofini, S., Vangone, B.E., Carrara, C., Bocchia, M., Gozzetti, A. (2025). Efficacy and Safety of Teclistamab Followed by Autologous Stem Cell Transplant in Functional High-risk and Triple-class Refractory Multiple Myeloma. MEDITERRANEAN JOURNAL OF HEMATOLOGY AND INFECTIOUS DISEASES, 17(1) [10.4084/MJHID.2025.051].
File in questo prodotto:
File Dimensione Formato  
Efficacy and safety of teclistamab followed by autologous stem cells transplant-Sammartano-2025.pdf

accesso aperto

Descrizione: Articolo
Tipologia: PDF editoriale
Licenza: Creative commons
Dimensione 529.64 kB
Formato Adobe PDF
529.64 kB Adobe PDF Visualizza/Apri

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11365/1314334